Learn more about Euretos computational disease model and how it predicts many of the known drug targets for RA.
In this case study you will learn about:
- How Euretos has contributed to real world results for five different biopharma clients, including approved drugs and active clinical trials in oncology, Sjogren's disease, Ulcerative Colitis, NASH and epilepsy.
- Our computational disease model and how it predicts many of the known drug targets for rheumatoid arthritis.
- How we predict over 200 novel targets for RA that have high scores and are prime candidates to consider.
Register your details to find out more.
Download Now
Case Study: Target discovery for rheumatoid arthritis
PDF, Size 0 kb
Topics
- 3D Cell Cultures
- Analytical Techniques
- Artificial Intelligence (AI)
- Assays
- Biomarkers
- Biopharmaceuticals
- Biotechnology & Bioengineering
- Disease Research
- Drug Delivery
- Euretos
- Genome Editing
- High-Throughput Screening (HTS)
- Immunology
- Informatics
- Lipidomics
- Monoclonal Antibodies
- Personalised Medicine
- Sequencing
- Stem Cells
